PUBLIC CONTRACT · 2017
Aquisição de Mepolizumab 100 mg pó sol inj fr SC
- Contract value
- €8,379.92
- Signed on
- 16 November 2017
- Procedure
- Direct award, general (Ajuste Direto Regime Geral)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 4392561PUBLISHED SUBJECT
Aquisição de Mepolizumab 100 mg pó sol inj fr SC
WHO CONTRACTED
Parties involved
- Place of performance
- Portugal, Porto, Vila Nova de Gaia
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- GlaxoSmithKline, Lda · Tax ID 500139962
HOW MUCH AND WHEN
Values and timeline
- Contract price
- €8,379.92
- Procedure base price
- €10,474.90
- Total effective price
- Not reported on Portal BASE
- Publication date
- 5 April 2018
- Award date
- 16 November 2017
- Signing date
- 16 November 2017
- Performance period
- 45 days
The contract price is the value agreed in the contract, not the amount paid.
HOW IT WAS CONTRACTED
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Direct award, general (Ajuste Direto Regime Geral)
- Award criterion
- Not stated
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 24.º, n.º 1, alínea e) do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL 18/2008)
- Framework agreement
- Not stated
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 2973401
KEEP EXPLORING
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.